# Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia

> **NCT00974051** · NA · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 16 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Terbutaline
- **OTHER:** 20% basal insulin reduction
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT00974051
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00974051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00974051, "Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00974051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*